Acer Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Acer Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2023.
  • Acer Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2023 was 24.5M shares, a 52.1% increase year-over-year.
  • Acer Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 15.8M shares, a 10.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 24.5M +8.37M +52.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 24.5M +9.19M +60.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 21.1M +6.8M +47.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 15.8M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-27
Q3 2022 16.1M +1.78M +12.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 15.3M +963K +6.73% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 14.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 14.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 14.3M Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.